IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model-Reference-Cited by-同舟云学术

IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model

Published:2023-03 Issue:3 Volume:31 Page:340-350
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

van Gemert Y.^ORCID,Kruisbergen N.N.L.,Blom A.B.^ORCID,van den Bosch M.H.J.^ORCID,van der Kraan P.M.,Pieterman E.J.,Princen H.M.G.^ORCID,van Lent P.L.E.M.

Funder

ReumaNederland

Dutch Arthritis Association

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference50 articles.

1. Osteoarthritis: a disease of the joint as an organ;Loeser;Arthritis Rheum,2012

2. Association between metabolic syndrome and knee osteoarthritis: a cross-sectional nationwide survey study;Lee;J Rehabil Med,2019

3. Relationship between metabolic syndrome and osteoarthritis: the Fasa Osteoarthritis Study;Askari;Diabetes Metab Syndr,2017

4. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data;Puenpatom;Postgrad Med,2009

5. Metabolic factors and oxidative stress in osteoarthritis: a case–control study;Tootsi;Scand J Clin Lab Invest,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoarthritis year in review 2023: Biology;Osteoarthritis and Cartilage;2024-02

2. Cholesterol, systemic inflammation, interleukin-1β, and osteoarthritis risk — aligning animal models with specific patient endotypes provides novel insights;Osteoarthritis and Cartilage;2023-03